Ignite Creation Date:
2025-12-26 @ 10:46 PM
Ignite Modification Date:
2025-12-26 @ 10:46 PM
Study NCT ID:
NCT00116012
Status:
COMPLETED
Last Update Posted:
2006-11-29
First Post:
2005-06-26
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Anticoagulation With rNAPc2 to Eliminate MACE/TIMI 32
Sponsor:
ARCA Biopharma, Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
NUVO-0201
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |